Thrombin-jmi Liquid
NDC Package 60793-333-01
Package Information
Thrombin-jmi (thrombin, topical (bovine)) liquids is tHROMBIN-JMI LIQUID is a topical bovine thrombin indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical.In various types of surgeries, solutions of THROMBIN-JMI LIQUID may be used in conjunction with an Absorbable Gelatin Sponge, USP for hemostasis. This formulation utilizes a liquid delivery system. Marketed by Pfizer Laboratories Div Pfizer Inc, this product is identified by NDC 60793-333 and is authorized under FDA application BLA102865.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60793 - Pfizer Laboratories Div Pfizer Inc
- 60793-333 - Thrombin-jmi
- 60793-333-01 - 1 VIAL, SINGLE-DOSE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-DOSE (60793-333-05)
- 60793-333 - Thrombin-jmi
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60793-333-01 identifies a specific commercial package of 1 vial, single-dose in 1 carton / 5 ml in 1 vial, single-dose (60793-333-05) of Thrombin-jmi, a plasma derivative labeled by Pfizer Laboratories Div Pfizer Inc. This liquid is formulated for topical use and contains thrombin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Laboratories Div Pfizer Inc on August 31, 2026. The current certification is valid through December 31, 2027.
How is this Pfizer Laboratories Div Pfizer Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60793033301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.